Novo Nordisk A/S
NVO
Company Profile
Business description
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Contact
Novo Alle 1
Bagsvaerd 2880
DNKT: +45 44448888
E: phak@novonordisk.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
66,015
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,132.10 | 49.80 | 0.62% |
CAC 40 | 8,195.97 | 28.47 | 0.35% |
DAX 40 | 18,768.96 | 64.54 | 0.35% |
Dow JONES (US) | 39,806.77 | 196.82 | -0.49% |
FTSE 100 | 8,424.20 | 3.94 | 0.05% |
HKSE | 19,636.22 | 82.61 | 0.42% |
NASDAQ | 16,794.87 | 108.91 | 0.65% |
Nikkei 225 | 39,069.68 | 282.30 | 0.73% |
NZX 50 Index | 11,735.71 | 35.92 | 0.31% |
S&P 500 | 5,308.13 | 4.86 | 0.09% |
S&P/ASX 200 | 7,863.70 | 49.30 | 0.63% |
SSE Composite Index | 3,171.15 | 17.12 | 0.54% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Sayona Mining Ltd SYA | 0.05 | 0.00 | -7.55% |
The Star Entertainment Group Ltd SGR | 0.54 | 0.09 | 20.00% |
Peninsula Energy Ltd PEN | 0.12 | 0.01 | 7.14% |
Imugene Ltd IMU | 0.07 | 0.00 | -4.17% |
South32 Ltd S32 | 3.89 | 0.13 | 3.46% |
Silver Mines Ltd SVL | 0.22 | 0.03 | 13.16% |
Telstra Group Ltd TLS | 3.67 | 0.00 | 0.00% |
Alligator Energy Ltd AGE | 0.07 | 0.01 | 8.33% |
Pilbara Minerals Ltd PLS | 4.20 | 0.10 | 2.44% |
De Grey Mining Ltd DEG | 1.20 | 0.04 | 3.00% |